Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 6, 1996, Pages 852-853

  Hill, G ^a   McClean, D ^a   Fraser, R ^a   Hart, D ^a   Crozier, I ^a   Snowden, J ^a   Gibbons, S ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; COR PULMONALE; FATALITY; FEMALE; HUMAN; LETTER; LUNG EMBOLISM; MEGAKARYOCYTE; MIDDLE AGED; MYELOFIBROSIS; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; THROMBOCYTHEMIA;

FATAL OUTCOME; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MEGAKARYOCYTES; MIDDLE AGED; MYELOFIBROSIS; PULMONARY EMBOLISM; PULMONARY HEART DISEASE; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 0030330278     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb00642.x     Document Type: Article

References (6)

1. Ward HP, Block MH. The natural history of agnogenic myeloid metaplasia and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1979; 50: 357-413.
2. Norman IL, Allen EV. The vascular complications of polycythemia. Am Heart J 1937; 13: 257-74.
3. Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1-12.
4. Reisner SA, Rinkevich D. Markiewicz W, Tatarsky I, Brennar B. Cardiac involvement in patients with myeloproliferative disorders. Am J Med 1992; 93: 498-504.
5. Glew RH, Haese WH, McIntrye PA. Myeloid metaplasia with myelofibrosis. The clinical spectrum of extramedullary haematopoiesis and tumour formation. Johns Hopkins Med J 1973; 132: 253-70.
6. Kaufman RM, Airo R, Pollack S, Crosby WH. Circulating megakaryocytes and platelet release in the lung. Blood 1965; 26: 720-31.